Newsroom
Market News
Both sides of the trade, grades and news round-ups. Click a headline to read it — the arrows walk the list.
Research
- Apple Stock Analysis: Buy, Hold, or Sell After Huge Investor Update?
- Stock News Roundup: Crypto Surge, Earnings Reports, and Market Analysis
- SOLUSD Recent News Highlights
- ADAUSD Recent News Highlights
- XRPUSD Recent News Highlights
- ETHUSD Recent News Highlights
- BTCUSD Recent News Highlights
- Molina Healthcare, Inc. Faces Class Action Lawsuits for Securities Fraud
- Mineral News: Third Quarter Financial Results and Investment Updates
- Latest Updates in the Stock Market
- Cipher Mining Surges on $5.5 Billion Amazon AI Lease Agreement
- Quarterly Performance Recap: Bancorp 34, Inc and Other Financial Institutions
- Savara Inc. Faces Shareholder Lawsuits Amidst Participation in Healthcare Conferences
- AMD Earnings: Key to Sustaining Stock Rally
- Investigation into Stride, Inc. Sparks Stock Volatility
- Vertex Falls 10% After Reporting Mixed Q3 Results
- Tronox Holdings plc Class Action Lawsuit Update
- Synopsys, Inc. Faces Class Action Lawsuit for Securities Fraud
- Starbucks Sells Majority Stake in China Business to Boyu Capital for $4 Billion
- Marex Group plc Securities Fraud Class Action Lawsuit Updates
- MoonLake Immunotherapeutics Faces Class Action Lawsuit Deadline
- Analyzing the Future of S&P 500 Stocks: Will the Growth Spurt Continue?
- Fly-E Group, Inc. Faces Securities Fraud Lawsuits Amidst Class Action Allegations
- Cytokinetics Class Action Lawsuits: Investors Urged to Seek Legal Counsel Before November 17th
- CrowdStrike Receives Price Target Boost on AI Momentum
- Class Action Lawsuits Filed Against Baxter International Inc. (BAX)
- Securities Fraud Investigation Into Avantor, Inc. (AVTR) Announced
- ATYR Pharma, Inc. Faces Class Action Securities Lawsuit
- Class Action Against WPP plc: Deadline Approaching for Investors – Contact Legal Firms Now
- Pfizer's Antitrust Battle: Novo Nordisk Outbids in Obesity Biotech Acquisition
- Lantheus Holdings, Inc. Faces Multiple Class Action Lawsuits
- Meta Platforms Inc. and Stock Market Insights
- UniQure N.V. Faces Securities Fraud Investigation After FDA Rejects Clinical Data for Huntington's Therapy
- Fluor Corporation Faces Multiple Class Action Lawsuits for Securities Fraud
- Diamondback Energy Reports Profit and Revenue Surge Amid Global Oil Glut Concerns
- Beyond Meat, Inc. Faces Securities Fraud Investigation, Earnings Delayed
- Ryanair Holdings plc Reports Strong Earnings Growth in Q2 2026
- IDEXX Laboratories Surges 15% on Strong Q3 Earnings and Guidance Raise
- Ambetter from Health Net Offers Health Insurance in California for 2026
- VFC Investors Alerted to Securities Fraud Class Action Lawsuit Deadlines
Ask the market a question. Get a calculated answer.
The AI is not a chatbot bolted onto a document store. It calls the same analytics engine that powers every screen on this platform — so what comes back is a number it computed from raw history, with the command that produced it.
86,000+ instruments
Global equities, ETFs, funds, options, FX, commodities, crypto, economics, filings, transcripts and news — one normalised symbol universe with adjusted history.
A real analytics engine
Screening, backtesting, technicals, options analytics, correlations, seasonality and factor models — computed on demand from raw prices, never a stale cache.
It shows its working
Answers arrive with the charts, tables and tool calls behind them, so you can check the number instead of trusting a paraphrase.
Your own documents
Upload filings, decks and research. Ask across them and the answer cites the page it came from.
Agents and workflows
Multi-step research that runs the platform's tools for you — screen, pull the history, compute, compare, then write it up.
MCP, CLI and API
The same command catalogue from Claude, your own agent, a shell or your pipeline. The answer on screen is the answer your job gets at 4am.
You ask
“How does NVDA usually trade through earnings?”
It calls
→ ka.options_expected_move(NVDA)
It answers
NVDA has averaged a 9.2% absolute move on the day after earnings and closed higher 67% of the time. Two in three reactions land between −4.2% and +16.3% — the distribution is skewed right, not symmetric.
Every figure computed live from our own history — not scraped, not summarised.
Or start with